Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06383988 · ClinicalTrials.gov registry record · NA
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
A NA study of Stage IV Lung Cancer and Stage II Lung Cancer, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 20
- Study locations
NCT06383988 is a NA study of Stage IV Lung Cancer and Stage II Lung Cancer that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 216 participants, above the 136-participant average among 5 other Stage IV Lung Cancer trials with a reported enrollment target (59% higher). The trial reports 20 study locations across 9 states.
The verdict
NCT06383988, a NA study of Stage IV Lung Cancer and Stage II Lung Cancer, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 20
- Study locations
Study Summary
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigation
- OTHER Support for Caregiver - Generic List
- OTHER Support for Caregiver - Personalized List
- OTHER Internet-Based Intervention - CONNECT
Study Locations (20)
South Carolina
- Gibbs Cancer Center-Gaffney - Gaffney
- Prisma Health Cancer Institute - Butternut - Greenville
- Prisma Health Cancer Institute - Eastside - Greenville
- Gibbs Cancer Center-Pelham - Greer
- Spartanburg Medical Center - Spartanburg
- MGC Hematology Oncology-Union - Union
Colorado
- Kaiser Permanente-Franklin - Denver
- Kaiser Permanente - Rock Creek - Lafayette
- Kaiser Permanente - Lone Tree - Lone Tree
Delaware
- Beebe South Coastal Health Campus - Millville
- Beebe Health Campus - Rehoboth Beach
Hawaii
- Hawaii Cancer Care Inc - Waterfront Plaza - Honolulu
- Hawaii Cancer Care - Westridge - ‘Aiea
Missouri
- Lake Regional Hospital - Osage Beach
- CoxHealth South Hospital - Springfield
Pennsylvania
- Community Medical Center - Scranton
- Geisinger Wyoming Valley/Henry Cancer Center - Wilkes-Barre
Georgia
- Augusta University Medical Center - Augusta
New York
- Montefiore Medical Center-Einstein Campus - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2024-11-11 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06383988
The ClinicalTrials.gov registry entry for NCT06383988 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 136-participant average among 5 other Stage IV Lung Cancer trials with a reported enrollment target (59% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stage IV Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Patient Navigation is the first listed.
NCT06383988 reports 20 study locations spanning 9 distinct geographic areas - top geographies include South Carolina, Colorado, Delaware.
Frequently Asked Questions
What is clinical trial NCT06383988 about?
NCT06383988 is a clinical study titled "A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources". Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community o...
What is the current status of trial NCT06383988?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2024-11-11. Estimated completion is 2026-07-30.
What conditions does trial NCT06383988 study?
This clinical trial studies the following conditions: Stage IV Lung Cancer, Stage II Lung Cancer, Stage III Lung Cancer.
What interventions are being tested in trial NCT06383988?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), Support for Caregiver - Generic List (OTHER), Support for Caregiver - Personalized List (OTHER), Internet-Based Intervention - CONNECT (OTHER).
Who is sponsoring clinical trial NCT06383988?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06383988 being conducted?
This trial has 20 study locations across Colorado, Delaware, Georgia, Hawaii, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care
RECRUITING · NA
-
Ask Questions (ASQ):Implementation of a Communication Intervention
COMPLETED · NA
-
Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
RECRUITING · Phase 1
-
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
RECRUITING
-
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.